knowledge -WSS

knowledge

author：Wikipedia 2025-09-06 04:39:28 - browse：3

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： The problem with charging patients to message their doctors

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Headspace, Meta partner to launch VR meditation app for Quest

Why Titanic fascinates society, still drawing tours to the wreckage

Neutralizing antibodies against HIV shows promise in children

IVF, abortion rights issues kick off Biden’s State of the Union

NEJM study link tiny plastics in blood vessels to heart problems

knowledge

knowledge

knowledge

Activists slam private health insurers over coverage restrictions

With psoriasis trial ahead, Alumis raises $259 million

Jerome Adams on the need for new antivirals for Covid

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Jerome Adams on the need for new antivirals for Covid

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

In Memoriam: Notable people who died in 2023

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

hotspot

NEJM study link tiny plastics in blood vessels to heart problems

Trump seeks lengthy delay of classified docs trial, citing upcoming election

North Korean leader's powerful sister says warplanes repelled US spy plane

Change Healthcare cyberattack prompts Medicare loan program

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

hotspot

hotspot

focus

leisure time